Tomohiko Kanaoka Selected Research

Therapeutics

4/2024	Correction to: Two acute kidney injury episodes after ICI therapy: a case report.
3/2024	Two acute kidney injury episodes after ICI therapy: a case report.
12/2022	Cardiovascular and kidney outcomes of combination therapy with sodium-glucose cotransporter-2 inhibitors and mineralocorticoid receptor antagonists in patients with type 2 diabetes and chronic kidney disease: A systematic review and network meta-analysis.
3/2022	Prevention of kidney function decline using uric acid-lowering therapy in chronic kidney disease patients: a systematic review and network meta-analysis.
1/2022	Comparative Efficacy of Pharmacological Treatments for Adults With Autosomal Dominant Polycystic Kidney Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.
12/2015	Effects of pitavastatin add-on therapy on chronic kidney disease with albuminuria and dyslipidemia.
5/2015	Effects of the oriental herbal medicine Bofu-tsusho-san in obesity hypertension: a multicenter, randomized, parallel-group controlled trial (ATH-D-14-01021.R2).
1/2014	Effects of single pill-based combination therapy of amlodipine and atorvastatin on within-visit blood pressure variability and parameters of renal and vascular function in hypertensive patients with chronic kidney disease.
4/2013	Therapeutic potential of low-density lipoprotein apheresis in the management of peripheral artery disease in patients with chronic kidney disease.
1/2013	Rituximab treatment for adult purpura nephritis with nephrotic syndrome.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Tomohiko Kanaoka Research Topics

Disease

15	Hypertension (High Blood Pressure) 01/2023 - 11/2009
13	Chronic Renal Insufficiency 05/2024 - 01/2011
8	Type 2 Diabetes Mellitus (MODY) 05/2024 - 01/2011
4	Obesity 04/2023 - 01/2013
4	Albuminuria 01/2022 - 07/2013
4	Body Weight (Weight, Body) 01/2020 - 01/2013
3	Fibrosis (Cirrhosis) 11/2021 - 10/2011
3	Abdominal Obesity 01/2014 - 01/2013
3	Proteinuria 03/2013 - 11/2009
2	Acute Kidney Injury (Acute Renal Failure) 04/2024 - 03/2024
2	Peripheral Arterial Disease 04/2024 - 04/2013
2	Ureteral Obstruction 01/2020 - 06/2013
2	Inflammation (Inflammations) 01/2020 - 10/2011
2	Dyslipidemias (Dyslipidemia) 12/2015 - 04/2013
2	Hypertrophy 01/2014 - 12/2013
1	Hyperemia 04/2024
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 03/2024
1	VEXAS syndrome 01/2024
1	Giant Cell Arteritis (Horton Disease) 01/2024
1	Peritonitis 01/2024
1	Chronic Kidney Failure (Chronic Renal Failure) 11/2023
1	Hyperaldosteronism (Conn Syndrome) 01/2023
1	Hyperkalemia 12/2022
1	COVID-19 12/2022
1	Hyperuricemia 03/2022
1	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022
1	Anemia 07/2020
1	Cardiomegaly (Heart Hypertrophy) 08/2013

Drug/Important Bio-Agent (IBA)

6	Glucose (Dextrose)FDA LinkGeneric 12/2023 - 01/2011
6	Therapeutic UsesIBA 01/2022 - 10/2011
5	SodiumIBA 12/2023 - 09/2014
5	Angiotensin IIIBA 09/2014 - 01/2013
5	Proteins (Proteins, Gene)FDA Link 09/2014 - 07/2011
4	Antihypertensive Agents (Antihypertensives)IBA 01/2013 - 01/2011
3	Sodium-Glucose Transport ProteinsIBA 05/2024 - 01/2021
3	Glucagon-Like Peptide-1 Receptor AgonistsIBA 12/2023 - 01/2022
3	AldosteroneIBA 01/2023 - 07/2013
3	Type 1 Angiotensin ReceptorIBA 09/2014 - 10/2010
3	CreatinineIBA 01/2014 - 01/2011
3	olmesartanIBA 01/2014 - 10/2011
3	AlbuminsIBA 01/2014 - 01/2011
3	aliskiren FDA Link 07/2013 - 01/2012
2	SymportersIBA 12/2023 - 03/2022
2	Glucagon-Like Peptide 1 (GLP 1)IBA 01/2022 - 01/2021
2	Sodium-Glucose Transporter 2 InhibitorsIBA 01/2022 - 01/2021
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2021
2	oxidized low density lipoproteinIBA 12/2015 - 04/2013
2	Amlodipine (Norvasc)FDA LinkGeneric 01/2014 - 01/2012
2	Angiotensin Receptor AntagonistsIBA 01/2014 - 07/2013
2	Messenger RNA (mRNA)IBA 06/2013 - 07/2011
2	Angiotensin II Type 1 Receptor BlockersIBA 03/2013 - 11/2009
1	Lipoproteins (Lipoprotein)IBA 04/2024
1	Tyr sulfate(1)- enkephalinamide-Leu (LETS)IBA 04/2024
1	AntioxidantsIBA 04/2024
1	Immune Checkpoint InhibitorsIBA 03/2024
1	IpilimumabIBA 03/2024
1	NivolumabIBA 03/2024
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2024
1	UbiquitinIBA 01/2024
1	Prednisolone (Predate)FDA LinkGeneric 01/2024
1	EnzymesIBA 01/2024
1	Indicators and Reagents (Reagents)IBA 01/2023
1	Adrenocorticotropic Hormone (ACTH)FDA Link 01/2023
1	esaxerenoneIBA 01/2023
1	mRNA VaccinesIBA 12/2022
1	Mineralocorticoid Receptor AntagonistsIBA 12/2022
1	Uric Acid (Urate)IBA 03/2022
1	Febuxostat FDA Link 03/2022
1	Tolvaptan FDA Link 01/2022
1	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2022
1	aristolochic acid I (aristolochic acid)IBA 11/2021
1	Darbepoetin alfa (Aranesp)FDA Link 07/2020
1	Erythropoietin FDA Link 07/2020
1	continuous erythropoietin receptor activator FDA Link 07/2020
1	liu-jun-zi-tangIBA 01/2020
1	GhrelinIBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 12/2015
1	LipidsIBA 12/2015
1	pentosidineIBA 12/2015
1	pitavastatin (itavastatin)FDA Link 12/2015
1	bofu-tsusho-sanIBA 05/2015
1	AngiotensinogenIBA 09/2014
1	Sodium-Hydrogen ExchangersIBA 09/2014
1	Interleukin-6 (Interleukin 6)IBA 01/2014
1	Atorvastatin (Lipitor)FDA Link 01/2014
1	Irbesartan FDA LinkGeneric 01/2014
1	4- ethoxymethylene- 2- phenyl- 2- oxazoline- 5- one (phOx)IBA 12/2013
1	ReninIBA 08/2013
1	N-Type Calcium Channels (N-Type Calcium Channel)IBA 08/2013
1	cilnidipineIBA 08/2013
1	AngiotensinsIBA 08/2013
1	Carrier Proteins (Binding Protein)IBA 07/2013

Therapy/Procedure

13	Therapeutics 04/2024 - 01/2011
2	Blood Component Removal (Apheresis) 04/2024 - 04/2013
1	Peritoneal Dialysis 01/2024
1	Catheters 11/2023
1	Kidney Transplantation 11/2023
1	High-Protein Diet 04/2023
1	Renal Dialysis (Hemodialysis) 12/2022
1	Diet Therapy (Therapy, Diet) 12/2015